Cite
HARVARD Citation
Chan, C. et al. (2018). Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes. European journal of ophthalmology. 28 (6), pp. 677-683. [Online].